AC
Aldebaran Capital Portfolio holdings
AUM
$101M
This Quarter Return
+2.25%
1 Year Return
+6.46%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$110M
AUM Growth
+$110M
(+2%)
Cap. Flow
+$1.78M
Cap. Flow
% of AUM
1.62%
Top 10 Holdings %
Top 10 Hldgs %
74.9%
Holding
37
New
1
Increased
6
Reduced
6
Closed
–
Top Buys
| 1 |
Cato Corp
CATO
|
$994K |
| 2 |
iShares Russell Mid-Cap Value ETF
IWS
|
$330K |
| 3 |
Aclaris Therapeutics
ACRS
|
$213K |
| 4 |
PMV Pharmaceuticals
PMVP
|
$130K |
| 5 |
AN2 Therapeutics
ANTX
|
$108K |
Top Sells
| 1 |
Hillenbrand
HI
|
$16.5K |
| 2 |
Bank of America
BAC
|
$13.5K |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
$10.6K |
| 4 |
Bunge Global
BG
|
$9.95K |
| 5 |
Occidental Petroleum
OXY
|
$2.84K |
Sector Composition
| 1 | Financials | 27.72% |
| 2 | Energy | 18.26% |
| 3 | Technology | 11.11% |
| 4 | Healthcare | 10.74% |
| 5 | Consumer Staples | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Berkshire Hathaway Class B
BRK.B
$1.09T
| $20.3M | 18.5% |
44,029
-23
| -0.1% | -$10.6K |
|
2
Microsoft
MSFT
$3.77T
| $10.3M | 9.39% |
23,902
-4
| -0% | -$1.72K |
|
|
3
Bunge Global
BG
$16.8B
| $9.8M | 8.95% |
101,418
-103
| -0.1% | -$9.95K |
|
|
4
Occidental Petroleum
OXY
$46.9B
| $9M | 8.21% |
174,559
-55
| -0% | -$2.84K |
|
5
Eli Lilly
LLY
$657B
| $6.9M | 6.29% |
7,783
| – | – |
|
|
6
Bank of America
BAC
$376B
| $5.75M | 5.25% |
144,921
-340
| -0.2% | -$13.5K |
|
|
7
Cato Corp
CATO
$81.1M
| $5.6M | 5.12% |
1,123,131
+199,195
| +22% | +$994K |
|
|
8
iShares Russell Mid-Cap Value ETF
IWS
$14.1B
| $5.46M | 4.98% |
41,260
+2,496
| +6% | +$330K |
|
9
Suncor Energy
SU
$50.1B
| $4.71M | 4.3% |
127,670
| – | – |
|
10
Chevron
CVX
$324B
| $4.29M | 3.91% |
29,121
| – | – |
|
11
abrdn Bloomberg All Commodity Strategy K-1 Free ETF
BCI
$1.7B
| $3.22M | 2.94% |
157,341
| – | – |
|
12
JPMorgan Chase
JPM
$829B
| $2.51M | 2.29% |
11,907
| – | – |
|
13
Verizon
VZ
$186B
| $1.94M | 1.77% |
43,156
| – | – |
|
14
Richardson Electronics
RELL
$142M
| $1.88M | 1.72% |
152,710
| – | – |
|
15
Enbridge
ENB
$105B
| $1.78M | 1.62% |
43,760
| – | – |
|
16
Freeport-McMoran
FCX
$63.7B
| $1.61M | 1.47% |
32,309
| – | – |
|
|
17
Berkshire Hathaway Class A
BRK.A
$1.09T
| $1.38M | 1.26% |
2
| – | – |
|
18
Patrick Industries
PATK
$3.72B
| $1.38M | 1.26% |
9,684
| – | – |
|
|
TECX
19
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
| $1.27M | 1.16% |
41,991
| – | – |
|
|
20
Aclaris Therapeutics
ACRS
$209M
| $1.2M | 1.1% |
1,043,152
+185,000
| +22% | +$213K |
|
|
21
Hillenbrand
HI
$1.79B
| $1.12M | 1.02% |
40,191
-595
| -1% | -$16.5K |
|
22
IES Holdings
IESC
$6.94B
| $1.08M | 0.99% |
5,411
| – | – |
|
23
Century Aluminum
CENX
$2.08B
| $1.03M | 0.94% |
63,430
| – | – |
|
24
Amylyx Pharmaceuticals
AMLX
$836M
| $874K | 0.8% |
269,803
| – | – |
|
|
OKUR
25
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$37.2M
| $769K | 0.7% |
452,116
+4,500
| +1% | +$7.65K |
|